First Manhattan’s Evotec EVO Stock Holding History

First Manhattan’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-225	Closed	-$2.64K	–	1439
2023 Q4	$2.64K	Buy	+225	New	+$2.21K	﹤0.01%	1263

Other funds holding EVO

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

QCG

Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

First Manhattan's EVO Position: Q1 2024 in Review

First Manhattan sold out of Evotec (EVO) in Q1 2024, closing a stake of 225 shares — an estimated $2.64K sold.

First Manhattan first reported a position in EVO in Q4 2023 and held it in 1 quarter. The position peaked at $2.64K in Q4 2023. 21 funds tracked by Wall St. Rank hold EVO as of Q1 2024.

First Manhattan reported no remaining Evotec position as of Q1 2024 after selling out during the quarter.
First Manhattan sold 225 Evotec shares in Q1 2024, an estimated $2.64K.
First Manhattan first reported a position in Evotec in Q4 2023 and held it in 1 quarter.
First Manhattan's Evotec position peaked at $2.64K in Q4 2023.
21 funds tracked by Wall St. Rank held Evotec as of Q1 2024.

Based on First Manhattan's 13F filing for Q1 2024, filed 15 May 2024.